强迫症（OCD）管理指南：减少症状和改善日常生活的实用策略

Overview

Vasculitis is a group of rare autoimmune conditions in which the immune system mistakenly attacks blood vessels, causing inflammation. This swelling can narrow, weaken, or scar vessels, limiting blood flow to organs and tissues. There are many types—ranging from those affecting large vessels (such as giant cell arteritis or Takayasu arteritis) to medium- or small-vessel forms (such as polyarteritis nodosa or ANCA-associated vasculitides like granulomatosis with polyangiitis). Severity varies widely; some forms are limited while others can be life-threatening if untreated. Early diagnosis and treatment greatly improve outcomes.

Because vasculitis can involve almost any organ system, care is often coordinated by a rheumatologist working with other specialists. Treatment aims to control inflammation (induce remission), prevent organ damage, reduce the chance of flares, and minimize medication side effects.

Signs & Symptoms

Symptoms depend on which vessels and organs are affected and can develop suddenly or gradually. General (systemic) signs often appear first and may include unexplained fever, profound fatigue, unintended weight loss, night sweats, muscle aches, or joint pain. Organ-specific clues help identify the type.

• Skin: purplish spots (purpura), rashes, ulcers, or nodules
• Nerves: numbness, tingling, weakness, or burning pain
• Lungs or airways: cough, shortness of breath, coughing up blood, or sinus problems
• Kidneys: high blood pressure, blood or protein in urine, reduced kidney function
• Digestive tract: abdominal pain, nausea, or blood in stool
• Heart or large vessels: chest pain, arm/leg claudication (pain with use), or pulse differences
• Eyes or brain: vision changes, severe headache (especially in giant cell arteritis), stroke-like symptoms, or jaw pain with chewing

Causes & Risk Factors

In most cases the exact trigger is unknown. Vasculitis is usually autoimmune—the immune system attacks vessel walls. Some forms are linked to infections, certain medications, cancers, or other autoimmune diseases (such as rheumatoid arthritis or lupus). Genetic factors and environmental exposures may play a role in susceptibility.

• Age: some types (e.g., giant cell arteritis) are more common after age 50; others affect children or young adults
• Sex: certain forms show sex differences (e.g., Takayasu more often in women)
• Infections or recent illness
• Smoking or other vascular risk factors
• Family history of autoimmune disease (modest contribution)
• Prior use of specific drugs or presence of another autoimmune condition

Diagnosis

Diagnosis requires a careful history, physical exam, and targeted tests because no single test confirms every type. Your doctor will rule out mimics such as infection, atherosclerosis, or other inflammatory diseases. Biopsy of affected tissue (skin, nerve, kidney, temporal artery, etc.) is often the gold standard when safe to obtain. Imaging (ultrasound, CT/MR angiography, PET) helps assess vessel involvement. Blood tests look for inflammation (ESR, CRP), organ function, and specific antibodies (e.g., ANCA).

• Blood and urine tests for inflammation, kidney/liver function, and autoantibodies
• Tissue biopsy when feasible
• Vascular imaging (angiography, ultrasound, CT, MRI, or PET-CT)
• Specialist referral (rheumatology, and often nephrology, pulmonology, neurology, or ophthalmology)

Treatment & Management

Treatment is individualized by vasculitis type, severity, organs involved, and patient factors (age, other illnesses, infection risk). The goals are rapid control of inflammation (induction), then lower-intensity therapy to maintain remission while limiting side effects. Never stop or adjust medicines without medical guidance.

Corticosteroids (such as prednisone) are the cornerstone for most forms and often start at higher doses, then taper. Additional immunosuppressants or biologics are added for moderate-to-severe disease or steroid-sparing: methotrexate, azathioprine, mycophenolate, cyclophosphamide (for severe organ-threatening disease), or targeted agents such as rituximab (especially ANCA-associated), tocilizumab (giant cell arteritis), or others. Plasma exchange may be used in select severe cases. Supportive care addresses blood pressure, clotting risk, bone protection, infection prevention, and organ-specific needs. Once controlled, many patients move to maintenance therapy lasting months to years, with close lab and clinical monitoring for flares or toxicity.

Living With It

Many people with vasculitis achieve good disease control and return to meaningful daily activities. Living well involves medication adherence, regular follow-up, infection vigilance, cardiovascular risk reduction, and attention to mental health. Flares can occur, so learn your personal warning signs and have a clear action plan with your care team. Lifestyle measures—balanced nutrition, appropriate physical activity, not smoking, and stress management—support overall vessel and organ health. Connect with reputable patient organizations for education and peer support.

Pregnancy planning, travel, work accommodations, and long-term bone/heart health should be discussed proactively with your specialists. With modern therapies and multidisciplinary care, the outlook for most forms of vasculitis has improved substantially.